Publication | Closed Access

Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case–control study from the LIPID study

Cardiovascular EpidemiologyCardiovascular DiseaseLipid StudyPharmacologyCardiovascular PharmacologyPravastatin TherapyHyperlipidemiaPharmacotherapyDyslipidemiaCardiovascular Disease EventsPublic HealthMedicineAtherosclerosisEpidemiology